For the purpose of this conversation let us say that there are 2 primary types of Leukemia, a sensitive subject for a person without medical training. But I want to tell you about a new breakthrough.
B-Cell Leukemia for the most part is treatable. However, until 2022 when the test studies began, T-Cell Leukemia was considered incurable, if there was no response to transplant or chemotherapy.
Scientists at University College London (UCL) and Great Ormond Street Hospital (GOSH) have developed a base‑edited CAR T‑cell therapy (called BE‑CAR7) that reprograms healthy donor T‑cells to attack the malignant T‑cells that drive T‑cell acute lymphoblastic leukemia (T‑ALL).
First patient treated in 2022 (a 13‑year‑old girl named Alyssa) had no response to chemo or bone marrow transplant, but BE‑CAR7 cleared her leukemia and she remains cancer‑free three years later.
That is the good news I wanted to share. Here is where I get-off. It is tremendously irresponsible for me to try to speak any further on this matter. Kudo’s to the UK. Complete information behind the links.
https://scitechdaily.com/teen-beats-deadly-leukemia-with-life-saving-gene-edited-cell-therapy
